Skip to main content
Top
Published in: Rheumatology International 1/2012

01-01-2012 | Original Article

Renal involvement in childhood-onset systemic lupus erythematosus in Egypt

Authors: Samia Salah-El-Din Mahmoud, Hafez Mahmoud Bazaraa, Hala Mohamed Lotfy, Doaa Mohamed Abd-El-Aziz

Published in: Rheumatology International | Issue 1/2012

Login to get access

Abstract

Lupus nephritis has been described as the most serious complication of systemic lupus erythematosus (SLE) and the strongest predictor of poor outcome. While the incidence of childhood SLE is relatively low, renal involvement appears to be more common and more severe in childhood SLE. This study aims to characterize the features and outcome of renal involvement in childhood-onset SLE based on a study of 100 Egyptian patients (mean age at diagnosis 10.1 years, range 2–17 years). Initial data regarding disease manifestations and biopsy findings were reviewed. Disease activity was assessed using SLEDAI scores. Follow-up data (mean duration 6 years) were noted regarding specific treatment, response, complications and renal survival. Initial renal involvement was present in 78 patients, including 66 with hypertension and 23 with renal impairment. Pathologically, class IV nephropathy was found in 18 patients, class V in 9 and low-grade lesions (class II–III) in 49. Twenty patients required follow-up biopsy, and all transformations were observed. SLEDAI scores significantly decreased from initial (mean ± SD) of 21.4 ± 7.3 to 13.4 ± 7.8, in association with response to therapy (P < 0.0001). Poor response was associated with initial hypertension and renal impairment but not with initial SLEDAI score or pathological class. The projected renal survival was 82.4 and 64.7% 5 and 10 years from diagnosis. Early renal involvement in childhood SLE is common, serious and requires proper evaluation and management.
Literature
1.
go back to reference Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheumat 43:1801–1808PubMed Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheumat 43:1801–1808PubMed
2.
go back to reference Perfumo F, Martini A (2005) Lupus nephritis in children. Lupus 14:83–88PubMed Perfumo F, Martini A (2005) Lupus nephritis in children. Lupus 14:83–88PubMed
3.
go back to reference Neuman K, Wallace DJ, Azen C, Naessim S, Fichman M, Metzger AL, Klinberg JR (1995) Lupus in the 1980s. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 25:47–55 Neuman K, Wallace DJ, Azen C, Naessim S, Fichman M, Metzger AL, Klinberg JR (1995) Lupus in the 1980s. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 25:47–55
4.
go back to reference Lewis EJ, Schwartz MM, Korbet SM (2001) Severe lupus nephritis, importance of reevaluating the histologic classification and the approach to patient care. J Nephrol 14:223–227PubMed Lewis EJ, Schwartz MM, Korbet SM (2001) Severe lupus nephritis, importance of reevaluating the histologic classification and the approach to patient care. J Nephrol 14:223–227PubMed
5.
go back to reference Bansal VK, Beto JA (1997) Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kid Dis 29:193–199PubMed Bansal VK, Beto JA (1997) Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kid Dis 29:193–199PubMed
6.
go back to reference Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158–166PubMed Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158–166PubMed
7.
go back to reference Mac Gowan JR, Ellis S, Griffiths M, Isenberg DA (2002) Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999. Rheumatology 41:981–987 Mac Gowan JR, Ellis S, Griffiths M, Isenberg DA (2002) Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999. Rheumatology 41:981–987
8.
go back to reference Petri M (2005) Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 31:245–254PubMed Petri M (2005) Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 31:245–254PubMed
9.
go back to reference Schwartz MM, Lewis EJ (2002) Rewriting the histological classification of lupus nephritis. J Nephrol 15(Suppl 6):S11–S19PubMed Schwartz MM, Lewis EJ (2002) Rewriting the histological classification of lupus nephritis. J Nephrol 15(Suppl 6):S11–S19PubMed
10.
go back to reference Wong SN, Tse KC, Lee TL, Lee KW, Chim S, Lee KP (2006) Lupus nephritis in Chinese children–a territory-wide cohort study in Hong Kong. Pediatr Nephrol 21:1104–1112PubMed Wong SN, Tse KC, Lee TL, Lee KW, Chim S, Lee KP (2006) Lupus nephritis in Chinese children–a territory-wide cohort study in Hong Kong. Pediatr Nephrol 21:1104–1112PubMed
11.
go back to reference Lee BS, Cho HY, Kim EJ, Kang HG, Ha IS, Cheong HI, Kim JG, Lee HS, Choi Y (2007) Clinical outcomes of childhood lupus nephritis: a single centre’s experience. Pediatr Nephrol 22:222–231PubMed Lee BS, Cho HY, Kim EJ, Kang HG, Ha IS, Cheong HI, Kim JG, Lee HS, Choi Y (2007) Clinical outcomes of childhood lupus nephritis: a single centre’s experience. Pediatr Nephrol 22:222–231PubMed
12.
go back to reference Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eeic-Marinkovic J (2004) Lupus nephritis in childhood: a review of 53 patients followed at a single centre. Pediatr Nephrol 19:36–44PubMed Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eeic-Marinkovic J (2004) Lupus nephritis in childhood: a review of 53 patients followed at a single centre. Pediatr Nephrol 19:36–44PubMed
13.
go back to reference Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S, García-Carrasco M, Seisdedos L, Ingelmo M (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459PubMed Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S, García-Carrasco M, Seisdedos L, Ingelmo M (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459PubMed
14.
go back to reference Iqbal S, Sher MR, Good RA, Cawkwell GD (1999) Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 135:500–505PubMed Iqbal S, Sher MR, Good RA, Cawkwell GD (1999) Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 135:500–505PubMed
15.
go back to reference Uthman IW, Muffarij AA, Mudawar WA, Nasr FW, Masri AF (2001) Lupus nephritis in Lebanon. Lupus 10:378–381PubMed Uthman IW, Muffarij AA, Mudawar WA, Nasr FW, Masri AF (2001) Lupus nephritis in Lebanon. Lupus 10:378–381PubMed
16.
go back to reference Yalaoui S, Gorgi Y, Meddeb S, Makin S, Lakhoua R, Debbabi A, Ayed K, Ben Maiz H, Hamza M (1993) Lupus in children in Tunisia. Rev Med Interne 14:765–771PubMed Yalaoui S, Gorgi Y, Meddeb S, Makin S, Lakhoua R, Debbabi A, Ayed K, Ben Maiz H, Hamza M (1993) Lupus in children in Tunisia. Rev Med Interne 14:765–771PubMed
17.
go back to reference Emre S, Bilge I, Sirin A, Kilicaslan I, Nayer A, Okten F, Uysal V (2001) Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 87:118–126PubMed Emre S, Bilge I, Sirin A, Kilicaslan I, Nayer A, Okten F, Uysal V (2001) Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 87:118–126PubMed
18.
go back to reference Huong DL, Papo T, Beaufils H, Wechsler B, Blétry O, Baumelou A, Godeau P, Piette JC (1999) Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single centre. Medicine (Baltimore) 78(3):148–166 Huong DL, Papo T, Beaufils H, Wechsler B, Blétry O, Baumelou A, Godeau P, Piette JC (1999) Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single centre. Medicine (Baltimore) 78(3):148–166
19.
go back to reference Gan HC, Hyoon KH, Fong KY (2002) Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH. Singapore Med J 43(12):614–616PubMed Gan HC, Hyoon KH, Fong KY (2002) Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH. Singapore Med J 43(12):614–616PubMed
20.
go back to reference Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT (2001) Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 135:248–257PubMed Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT (2001) Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 135:248–257PubMed
21.
go back to reference Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis-Hong Kong-Guangzhou nephrology study group. N Eng J Med 343:1156–1162 Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis-Hong Kong-Guangzhou nephrology study group. N Eng J Med 343:1156–1162
22.
go back to reference Baqi N, Moazami S, Singh A, Ahmed H, Balachandra S, Tejani A (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924–929PubMed Baqi N, Moazami S, Singh A, Ahmed H, Balachandra S, Tejani A (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7:924–929PubMed
23.
go back to reference Opastirakul S, Chartapisak W (2005) Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Pediatr Nephrol 20:1750–1755PubMed Opastirakul S, Chartapisak W (2005) Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Pediatr Nephrol 20:1750–1755PubMed
24.
go back to reference Hochberg MC (1990) Systemic lupus erythematosus. Rheum Dis Clin North Am 101:617–639 Hochberg MC (1990) Systemic lupus erythematosus. Rheum Dis Clin North Am 101:617–639
Metadata
Title
Renal involvement in childhood-onset systemic lupus erythematosus in Egypt
Authors
Samia Salah-El-Din Mahmoud
Hafez Mahmoud Bazaraa
Hala Mohamed Lotfy
Doaa Mohamed Abd-El-Aziz
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1554-7

Other articles of this Issue 1/2012

Rheumatology International 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.